Company news
Nuvo Pharmaceuticals Inc news in 2019
Nuvo Pharmaceuticals Inc's news releases, calls and decks from 2019, newest first.
Nuvo Pharmaceuticals(TM) Announces United States District Court Denies Dr. Reddy's Laboratories Motion for Summary Judgment of Nuvo's '996 and '920 VIMOVO Patents
November 11, 2019
Nuvo Pharmaceuticals(TM) Announces 2019 Third Quarter Results
October 31, 2019
Nuvo Pharmaceuticals(TM) Announces Third Quarter 2019 Results Release Date and Conference Call Details
October 17, 2019
Nuvo Pharmaceuticals(TM) to Present at H.C. Wainwright Global Investment Conference
September 4, 2019
Nuvo Pharmaceuticals(TM) Announces 2019 Second Quarter Results
August 14, 2019
Nuvo Pharmaceuticals(TM) Announces Second Quarter 2019 Results Release Date and Conference Call Details
July 31, 2019
Nuvo Pharmaceuticals(TM) Provides VIMOVO Patent Update
July 30, 2019
Nuvo Pharmaceuticals(TM) Provides Corporate Update
June 17, 2019
Nuvo Pharmaceuticals(TM) Announces that U.S. Court of Appeals for the Federal Circuit Reverses District Court's Decision Related to Certain Vimovo Patents
May 15, 2019
Nuvo Pharmaceuticals(TM) Announces 2019 First Quarter Results
May 14, 2019
Nuvo Pharmaceuticals(TM) to Present at the Bloom Burton & Co. Healthcare Investor Conference
April 23, 2019
Nuvo Pharmaceuticals(TM) Announces Pennsaid 2% Marketing Authorization Application Accepted for Review by AGES, the Austrian Agency for Health and Food Safety
April 2, 2019
Nuvo Pharmaceuticals(TM) Announces 2018 Fourth Quarter and Year-End Results
March 29, 2019
Nuvo Pharmaceuticals(TM) Announces the Filing of the Business Acquisition Report Related to the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets
March 15, 2019
Nuvo Pharmaceuticals(TM) Announces Receipt of Shareholder Approval By Way of Written Consent For the Issuance of Common Shares Pursuant to Convertible Notes and Warrants
March 11, 2019
Nuvo Pharmaceuticals(TM) Announces Appointment of Rob Harris as Executive Chairman
January 3, 2019
Nuvo Pharmaceuticals(TM) to Host Conference Call/Audio Webcast to Discuss the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets
January 2, 2019